Dabigatran etexilate

Dabigatran etexilate · Alembic Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

49 regulatory and trial events tracked for Dabigatran etexilate, covering 2010-12-17 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study). [Phase 4]

See pricing